News
WP7-SG3 guideline on “Therapeutic medical devices” is now available.
We are happy to announce that the final guideline on “Therapeutic medical devices” is now available. This document is the guideline on “Therapeutic medical devices”,
The 6th pilot rapid assessment of WP5 JA2 Strand B on “Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke” is now available
We are pleased to announce that the 6th pilot rapid assessment of WP5 JA2 Strand B on “Endovascular therapy using mechanical thrombectomy devices for acute
[CLOSED] Public Consultation for EUnetHTA JA2 WorkPackage4 Core HTA no.3
We are happy to announce that the third Core HTA produced within the EUnetHTA Joint Action 2 Work Package 4 is available for public feedback.
[CLOSED] Public Consultation for EUnetHTA JA2 WorkPackage4 Core HTA no.3
We are happy to announce that the third Core HTA produced within the EUnetHTA Joint Action 2 Work Package 4 is available for public feedback.
HTA is high on the European agenda for action
With the preparation of the Joint Action 3 on HTA switching into high gear, confirmation of the immediate practical relevance of the HTA activities are
EUnetHTA Joint Action 3 – formal preparatory work starting
The first formal meeting in preparation of the Joint Action 3 on HTA (as put forward in the 2015 Work Programme of the EU Health
EUnetHTA at ISPOR Milan, November 7-11, 2015
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is expecting as many as 5000 participants in its 18th Annual European Congress in Milan, Italy.
[CLOSED] Public consultation of the adapted methodological guideline “Endpoints used in Relative Effectiveness Assessment – Safety”
We are pleased to announce that as of today, 21 October, 2015, the methodological guideline “Endpoints used in Relative Effectiveness Assessment – Safety”, originally published
[CLOSED] Public consultation of Draft Assessment Report of the sixth pilot of WP5 Strand A: Rapid Relative Effectiveness Assessment of new pharmaceuticals for the treatment of chronic hepatitis C
We are pleased to announce that as of today, 15 October, the Second Draft Report focusing on the production of a Rapid Relative Effectiveness Assessment
[CLOSED] Public consultation of the draft methodological guideline “Therapeutic medical devices”
We are pleased to announce that as of today, 14 October, 2015, the draft methodological guideline “Therapeutic medical devices”, produced within WP7 – Subgroup 3,
